MAY 2021, VOLUME 5 ISSUE 5 `200 INDIA MED TODAY
Anatomy of Oxygen Crisis in India APPROACH Lending a Helping Hand FEATURE Distressed Diagnostic Labs IMPACT Diagnostics Vs COVID-19: The David versus Goliath Story MAY 2021
PULSE COVID-19 Second Wave in India
EDIT NOTE www.indiamedtoday.com
Vast Human Tragedy
MAY 2021 EDITORIAL Editor Neelam Kachhap Sub-Editor Abishek Raj editorial@ indiamedtoday.com ART & PRODUCTION ScreeTract Shylesh
BOARD OF ADVISORS Dr Alexander Thomas Dr Girdhar Gyani Dr Prem Kumar Nair Dr Bhabatosh Biswas
An acute health crisis emerged in the second half of April 2021 in India, claiming countless lives. The suffering and pain were
Dr Alok Roy
brought on by the deadly second wave of COVID-19. And this
Ramesh Kannan
time the death toll was huge. Almost every day more than four
CONSULTING EDITOR Dr Libert Anil Gomes Dr Salil Choudhary
lakh new case of COVID-19 were being reported and more than 3000 were dying since the second wave hit. We lost friends and family at an alarming rate, the pain more than what we could cope with. The industry struggled with the
ADVERTISING Gunjan Chauhan gunjanc@indiamedtoday.com The Media Ant help@themediaant.com DIGITAL MARKETING Vivek Nair Sales & Strategic Partnership Sujit Kaushik sujit.kaushik@indiamedtoday.com EDITORIAL ENQUIRIES editorial@indiamedtoday.com CUSTOMER SERVICE: Subscription support and other assistance for readers subscribe@indiamedtoday.com ADVERTISING ENQUIRIES sales@indiamedtoday.com OFFICE 301, Grazia, 1st main, 2nd Cross,
sudden onset of critically ill patients requiring ICU beds. Soon our hospitals were overwhelmed with a shortage of resources. Doctors both seniors and juniors took to social media to ask for help. Unprecedented, scenes of people gasping for breath among acute lack of oxygen began circulating through our phones. Desperate plea for bed, medicines and oxygen kept ringing through the day and night.
Our cover story this issue focuses on the glaring oxygen supply crunch and its effects. The story brings together experts in healthcare engineering and consultants who deliberate on the way out of the bottleneck. Our special feature looks at the diagnostic labs that have to bear the brunt of testing with a fast-turn-around time and keeping their staff safe and secure. Experts lay out the challenges and learnings during the COVID-19 pandemic. We also have a line-up of interesting stories related to the COVID-19 pandemic. These are aimed to help our readers to identify with and cope during these difficult times. Do write-to us and let us know your views. Send in your letters to editorial@indiamedtoday.com
Lingrajpuram, Bangalore 560084 www.indiamedtoday.com IndiaMedToday expressly disclaims liability for errors and omissions in this publication. While we try to keep the information timely and accurate, we make no guarantees. The views and opinions expressed in the magazine do not necessarily reflect the official policy or position of IndiaMedToday or the publication. Information on IndiaMedToday should not be used as a substitute for professional healthcare advice. Readers are advised to always seek specialist advice before acting on information contained in this publication. Never disregard professional medicaladvice or delay in seeking it
Editor M Neelam Kachhap
because of something you have read on IndiaMedToday. No part of this publication or any part of the contents thereof may be reproduced, stored in a retrieval system or transmitted in any form without the permission of the publishers in writing. Printed and published by M Neelam Kachhap, 301, Grazia, 1st main, 2nd Cross, Lingrajpuram, Bangalore 560084 on behalf of Neelam Publishing (OPC) Private Limited, Printed at Paradise Graphics, B-15, Mittal Tower, MG Road, Bangalore-1. and published at 301, Grazia, 1st main, 2nd Cross, Lingrajpuram, Bangalore 560084.
www.indiamedtoday.com
3
MAY 2021
CONNECT WITH US Join the conversation with IndiaMedToday through our social media pages Twitter
CONTENTS
18
15
34
APPROACH
IMPACT
FEATURE
Lending a Helping Hand
Diagnostics Vs COVID-19: The David versus Goliath Story
Distressed Diagnostic Labs
UPFRONT
20 COVER STORY
Anatomy of Oxygen Crisis in India
03 Editorial 06 News Roundup 32 Pulse 34 Report 36 Study Report 38 Detail News www.indiamedtoday.com
CHECKIT OUT ONLINE
LETTERS World Health day
T
he World Health Day 2021, and its goal of building a fairer and healthier world, allows us to reflect on our learnings from the COVID-19 pandemic. The pandemic has taught us that a country's healthcare system is just as much a part of its critical infrastructure as the ability to supply energy, water, or food. We have learned that independent national
healthcare initiatives do not work in a worldwide crisis; we need more international cooperation. The pandemic has also shown us that healthcare will become a community task. It will require a combination of both government and private responsibility. One of the irreversible outcomes of the pandemic is accelerated digitalization across all industries, including healthcare. The focus on collecting and harnessing the massive amount of healthcare data will make medicine more precise, ensuring the right treatment to the individual patient at the right time. Digital is emerging as the new normal in healthcare. Dileep Mangsuli, Head, Development Center, Siemens Healthineers
If the year 2020 was appalling because of the pandemic, then
has underlined the need for a resilient health system – not as an
beginning April 2021 the skewed graph of rising number of
option, but a necessity – to provide comprehensive, accountable,
patients in the second wave is a ruthless reminder that it is far
inclusive, and affordable quality health care to all.
from being over yet. In the last one year, the perception about healthcare workers and need for augmented focus towards
Poonam Muttreja, Executive Director of Population Foundation
investment in healthcare has underlined the need for affordable
of India
and accessible care. We must all consider that health is not a privilege it is a basic right! It is up to us, how we can make a difference in the lives of the needy. The theme for World Health Day 2021 is dedicated to ‘Building a Fairer, Healthier World for
Digital technology has transformed countless sectors in the last couple of decades. It has embarked a key role in the growth and advancement of the healthcare sector as well. Technological
Everyone’ the World Health Organization (WHO) calls for urgent
innovations
action to eliminate health inequities and mobilize action to attain
equalised the relationship between healthcare providers and
better health for all and leave no one behind.
patients. It continues to foster accessible, faster, cheaper and
Dr Alok Roy – Chair FICCI Health Services Committee & Chairman Medica Group of Hospitals The focus on public health today, brought on by the COVID-19 pandemic, must be leveraged to improve access to quality health care, an essential service for all. Universal health coverage is critical and must reach the most vulnerable. This pandemic
have
brought
sustainable
healthcare
systems,
effective solutions for diseases. Hospitals are gearing up to leverage data visualisation to maximise their medical efficiencies and also to present accurate health-related findings. Visualising health data is an effective way to share crucial health information quickly. Varun Babbar, MD, Qlik India
FOLLOW US ON... @indiamedtoday facebook.com/indiamedtoday PLS ADDRESS YOUR LETTERS TO: The Editor, IndiaMedToday and mail to editorial@indiamedtoday.com Pls indicate clearly if you want to publish you views/opinions for this page.
www.indiamedtoday.com
5
NEWS ROUNDUP Apollo Hospitals releases COVID-19 Red Book The Apollo Hospitals Group has developed a ready reckoner of Best Practice Guidelines for Hospitals, Nursing Homes and Healthcare Workers during this challenging period of the COVID pandemic. The COVID-19 Red Book summarises evidence-based best practice guidelines to support big and small healthcare institutions in making quick and timely decisions for diagnosis, treatment and management of COVID and non-COVID cases during the pandemic. The book also includes guidelines for non-clinical processes, policies, and protocols to improve efficiency and ensure a sound working environment. The guidelines will empower the healthcare institutions and the medical fraternity to react agilely to the evolving situation brought about by the second wave of the COVID pandemic.
Hospitals becomes India’s second-largest multi-speciality hospital chain. Today, the integrated organisation with the strong clinical expertise and breadth of services of Manipal Hospitals, complemented by the strengths of Columbia Asia in clinical and service quality, is uniquely placed to enhance access and address the growing demand for high quality tertiary and quaternary healthcare in the country.
Manipal Hospitals announced the successful completion of acquiring 100 per cent stake in Columbia Asia Hospitals (Columbia Asia). The transfer of ownership has taken place post the completion of all regulatory approvals. With this acquisition, Manipal
6
May 2021
data to ensure optimal use and better access to healthcare resources.
Syngene International extends research collaboration with Bristol Myers Squibb Syngene International has extended its
The acquisition helps Manipal Hospitals with a remarkable geographical and cultural fit that Columbia Asia offers to reach a larger national footprint.
ongoing
Cipla enters into a licensing agreement with MSD
discovery research conducted, including
Cipla has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co, Inc Kenilworth, NJ, USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of nonhospitalized patients with confirmed COVID-19. MSD is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics. This agreement is a part of Cipla’s efforts to enhance global access to treatments for patients affected by the pandemic. As part of the agreement, Cipla will be permitted to manufacture, market and distribute Molnupiravir in India and more than 100 low and middle-income countries. Cipla’s extensive geographical and commercial footprint will help make this therapy accessible to more patients and markets.
Verraton Health’s HIMS bags NDHM approval Manipal Hospitals acquires 100 per cent stake in Columbia Asia Hospitals
digital repository of all citizen’s healthcare
National Digital Health Mission (NDHM), Ministry of Health, Government of India has approved Verraton Health to implement its proprietary Hospital Information Management System (HIMS). The Maharashtra-based start-up is dedicated to creating an IT-based solution for the healthcare sector. Verraton Health is the fourth company among the other three from the government sector. The developed solution builds upon the government’s mission to create a massive
research
collaboration
with
Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years. The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq ft dedicated laboratory space.
Kiran Mazumdar-Shaw joins Board of Trustees of Memorial Sloan Kettering Cancer Center, US Biocon
announced
that
its
Executive
Chairperson Kiran Mazumdar-Shaw has been appointed to the Board of Trustees of Memorial Sloan Kettering Cancer Center (MSK), a world leader in cancer treatment and research, based in New York, US. She is among the 52 members on the board and will serve for a term of three years w.e.f. April 14, 2021. Mazumdar-Shaw is the first woman of Indian nationality to be appointed for this prestigious role. Memorial Sloan Kettering is ranked as one of the top two hospitals for cancer care in the US for more than 30 years and among the nation’s top paediatric
hospitals
for
cancer
care,
according to US News & World Report. Memorial Sloan Kettering maintains one of the world’s most dynamic programmes of cancer research, with more than 120 research laboratories that are focussed on better understanding every type of disease.
(mAbs) manufacturing facilities in India in terms of built area for a single building/ site. The first phase of the facility has been built at an investment of ~$120 million.
MSD ties up with five pharma majors in India for molnupiravir
Thermo Fisher Scientific’s Amplitude Solution
Thermo Fisher Scientific’s Amplitude Solution receives FDA nod for COVID-19 testing
COVID-19. The kit’s multi-gene target design and updated interpretive software may help labs detect SARS-CoV-2 variants.
in serving science, received emergency
Biocon Biologics facility wins ISPE’s 2021 FOYA Award
use authorization (EUA) from the US Food
Biocon Biologics has received the 2021
and Drug Administration (FDA) for Thermo
Facility of the Year Award (FOYA) from the
Fisher Scientific Amplitude Solution with
International Society for Pharmaceutical
the TaqPath COVID-19 High-Throughput
Engineering
Combo Kit. The modular solution processes
received an Honorable Mention award
samples in a four-step process requiring
for
minimum hands-on time, laboratory space
substances manufacturing facility located
and staffing resources. It was introduced
at Biocon Park, Bengaluru, a ~100-acre
as an automated real-time PCR test that
integrated complex with all infrastructure
can analyse up to 8,000 COVID-19 samples
and utilities. This is the first time that
in a single day. It empowers clinical and
a
public healthcare laboratories to scale
India has been awarded an ISPE FOYA
gold standard PCR testing with minimal
Honorable Mention. Every year, ISPE’s
staffing needs and a secured supply of
FOYA
kits, reagents and consumables to meet
the-art projects utilising new, innovative
the rising testing demands. The Amplitude
technologies to improve the quality of
Solution uses Thermo Fisher’s Applied
products, reduce the cost of producing
Biosystems
high-quality medicines and demonstrate
Thermo Fisher Scientific, the world leader
TaqPath
COVID-19
Combo
its
(ISPE).
monoclonal
biopharmaceutical
programme
The
company
antibodies
company
recognises
drugs
from
state-of-
Kit, a quick, highly sensitive multiplex
advances
diagnostic test that contains the assays
Biologics’ new 340,000-square feet B3
and controls needed for the qualitative
facility is being built in a modular manner
detection of nucleic acid from SARS-
to allow for expansion into Phase 2. This is
CoV-2, the virus responsible for causing
one of the largest monoclonal antibodies
in
project
delivery.
Biocon
Merck, known as MSD outside the US and Canada, has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generics manufacturers. Molnupiravir is an investigational oral antiviral agent currently being studied in a Phase 3 trial for the treatment of non-hospitalised patients with confirmed COVID-19. Merck is developing molnupiravir in collaboration with Ridgeback Biotherapeutics. Merck has entered into these agreements to accelerate the availability of molnupiravir in India and other low- and middle-income countries (LMICs) following approvals or emergency authorization by local regulatory agencies.
Digital therapeutics startup Fitterfly nets $3.1 million Indian digital therapeutics startup Fitterfly has raised $3.1 million in a preseries A round led by Fireside Ventures. Venture Catalysts and its accelerator fund 9Unicorns also participated in the round alongside a group of angel investors from India, the US, and Singapore, according to a statement. Fitterfly is a health-tech startup that offers therapy services and connects patients with health coaches and healthcare providers through voice and digital touchpoints. Its current suite of products includes programmes that address diabetes, PCOS, obesity, pregnancy, and child wellness.
Oxford scientists develop promising malaria shot A potential new malaria vaccine has proved highly effective in a trial in babies in Africa, pointing to it one day possibly helping reduce the death toll from the mosquito-borne disease that kills up to half a million young children a year. The candidate vaccine, developed by scientists
www.indiamedtoday.com
7
NEWS ROUNDUP at Britain’s University of Oxford and called R21/Matrix-M, showed up to 77 per cent efficacy in the year-long trial of 450 children in Burkina Faso, researchers leading the trial said in a statement.
wave
The scientists, led by Adrian Hill, director of Oxford’s Jenner Institute and also one of the lead researchers behind the OxfordAstraZeneca COVID-19 vaccine said they now plan to conduct final stage trials in some 4,800 children aged between 5months and 3 years in four African Countries.
Facemasks have (or must) become a default
IIT Mandi researchers develop anti-bacterial, self-cleaning material for face masks, PPE equipment
the case of reusable masks, which are a
Indian Institute of Technology Mandi researchers have developed a virusfiltering, self-cleaning and antibacterial material that can be used to make face masks and other PPE equipment. This path-breaking development of Dr Amit Jaiswal, Assistant Professor, School of Basic Sciences, IIT Mandi, along with his research scholars, Praveen Kumar, Shounak Roy and Ankita Sarkar comes at a time in which it has become imperative to develop techniques to stop the second
of
the
COVID-19
pandemic
in
the country. Results of this work have recently been published in the journal of the American Chemical Society – Applied Materials & Interfaces.
piece of apparel to be worn in public in these pandemic times. They are largely designed to act as a physical barrier between the wearer and the external environment, but in reality, must also act as anti-microbial agents to inhibit or kill pathogens. This is especially important in necessary alternative to single-use masks that add to littering and pollution issues, and secondary infections.
IIT Kharagpur commercialises COVIRAP IIT
Kharagpur
commercialised
its
has flagship
successfully healthcare
product – COVIRAP – the novel diagnostic technology to zero in on infectious diseases including COVID-19, the institute said. The product, developed by lead researchers Professor Suman Chakraborty, Dr Arindam Mondal and their research group, has been licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
Zydus Cadila’s Virafin gets DCGI’s nod for COVID-19 treatment Zydus Cadila has received restricted emergency use approval from the Drug Controller General of India (DCGI) to use the antiviral drug Virafin for the treatment of moderate COVID-19 infections. A single dose subcutaneous regimen of the antiviral drug will make treatment of COVID-19 disease more convenient. In its regulatory filing, the company said, “When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications. Virafin will be available on the prescription of medical specialist for use in hospital/institutional setup.”
Meitra Hospital collaborates with MGM Healthcare Meitra Hospital has collaborated with Chennai-based MGM Healthcare to set up comprehensive heart and lung as well as liver transplant programmes. Faizal E Kottikollon, Chairman, Meitra Hospital and Dr KR Balakrishnan, Director at Institute of Heart & Lung Transplant & Mechanical Circulatory Support at MGM Healthcare and Dr Thiagarajan Srinivasan, Director,
Dr Amit Jaiswal, Assistant Professor, School of Basic Sciences, IIT Mandi, Praveen Kumar, Shounak Roy and Ankita Sarkar
8
May 2021
Team of medical experts Institute of Liver Diseases, Transplant & HPB Surgery, MGM Healthcare signed the Memorandum of Understanding (MoU). Dr Ali Faizal, Director, Meitra Hospital and Harish Manian, CEO, MGM Healthcare were present at the MoU signing ceremonies. Through the heart and lung transplant programme, Meitra Hospital aims to advance its reputed Centre of Excellence for Heart and vascular care by offering heart and lung transplants, mechanical circulatory support devices for failing hearts and single lung retrieval and transplant. The transplant programme will be led by an expert team that does the highest number of heart and lung transplants in Asia.
Barco India partners with Sigma – Jones AV Barco, a market leader in visualisation and collaboration technology, announced its partnership with Sigma – Jones AV to deliver best-in-class digital experiences in healthcare for its next-gen operating room video integration solution Nexxis. Barco leverages Nexxis, its video-overIP platform for digital integration in the operating room to deliver precise imagery, efficient workflow, and maximise flexibility across the increasingly complex Operating Room (OR) procedures globally. Jones AV is one of the most successful Barco Nexxis partners to have developed a tried and tested Nexxis platform.
Featuring one of the largest install bases and some of the most complex and innovative solutions for fully integrated state-of-the-art operating theatres across Europe, Sigma AVIT is one of India’s leading premium Corporate AV System integrators and has a pan Indian network of offices and engineers. The synergies in Sigma – Jones AV add value to hospitals by bringing the longstanding experience in operating theatre integration from Europe with an unparalleled service network and local experience.
mental-health digital platform MANAS
SpiceXpress signs agreement with B Medical Systems
national digital wellbeing platform and
SpiceXpress, the cargo arm of SpiceJet airline, signed an agreement with Luxembourg-based B Medical Systems for safe, reliable and temperature-controlled transportation of COVID-19 vaccine across India. With an aim to expand the basket of COVID-19 vaccines and enhance the pace of inoculation in India, the central government had announced fast-track emergency approval for foreign-produced jabs that have been granted similar clearances in other countries. The government’s move is significant as it may make available several vaccines, including those made by Pfizer, Moderna and Johnson & Johnson, in India with certain conditions.
Govt launches community
The Principal Scientific Adviser to the Government of India Prof K Vijay Raghavan virtually launched the MANAS App to promote wellbeing across age groups. MANAS which stands for Mental Health and Normalcy Augmentation System was endorsed as a national programme by the Prime Minister’s Science, Technology, and Innovation Advisory Council (PM-STIAC). MANAS is a comprehensive, scalable, and an app developed to augment the mental well-being of
Indian citizens. MANAS
App integrates the health and wellness efforts of various government ministries, scientifically validated indigenous tools with
gamified
interfaces
developed/
researched by various national bodies and research institutions. MANAS was initiated by the Office of the Principal Scientific Adviser to the Government
of
India.
It
was
jointly
executed by NIMHANS Bengaluru, AFMC Pune and C-DAC Bengaluru.
CSIR-CMERI develops oxygen enrichment technology CSIR-CMERI
has
developed
‘Oxygen
Enrichment’ technology which has been transferred virtually to Apollo Computing Laboratories,
Kushaiguda,
Hyderabad.
www.indiamedtoday.com
9
NEWS ROUNDUP
(Right) Prof (Dr) Harish Hirani, Director, CSIR-CMERI On this occasion, Prof (Dr) Harish Hirani,
state-of-the-art cancer care centre and a
Director,
the
palliative care centre in Bhubaneswar. The
unit requires easily available oil-free
first MoU was signed for Bagchi-Sri Shankar
reciprocating compressor, oxygen grade
Cancer Centre and Research Institute by
zeolite sieves and pneumatic components.
the state government, Susmita Bagchi and
It is capable of delivering medical air in the
Shri Shankar Cancer Foundation. The MoUs
range of up to 15 LPM with oxygen purity
were signed in presence of Chief Minister
of more than 90 per cent. If required, this
Naveen Patnaik. The centre will provide a
unit can even deliver up to 70 LPM at a
global standard cancer treatment facility
purity of around 30 per cent and can safely
to people in Odisha and from the eastern
be placed in the isolation ward of the
region of the country.
CSIR-CMERI
said
that
hospital for patients who are in dire need of oxygen. This will help the accessibility of oxygen in the remotest places and widest points of need. The outreach factor of oxygen will be multiplied through the adoption of this in-situ and decentralised generation of oxygen.
The second MoU was inked for BagchiKarunashraya Palliative Care Centre by the state government, Susmita Bagchi and Karunashraya Hospice Trust. The centre will provide high-quality palliative care, peace and dignity to patients in their last few days.
He also added that further research is
inhalation only. This mode is supposed to
West expands partnership with Venus Remedies
reduce the oxygen demand by around 50
West Pharmaceutical Services (West), a
per cent when compared with the current
global leader in innovative solutions for
version of continuous mode.
injectable drug administration, recently
Odisha signs MoUs for cancer hospital and palliative care centre
announced its partnership with domestic
going on to develop a pulse dose mode that is capable of sensing the breathing pattern of a patient and then deliver during the
The
signed
brand
Cloti-Xa
has
made
its
introduction in the growing low molecular weight heparin market and has adopted the NovaGuard SA Pro safety system,
Memorandums of Understanding for a
a single-use accessory for prefilled ISO
May 2021
government
whose
two
10
Odisha
Indian pharma company Venus Remedies
standard 1mL long staked-needle syringes. The NovaGuard SA Pro safety system is a product with innovative safety features that help protect healthcare workers and patients from accidental needlestick injuries. Several biopharmaceutical manufacturers have commented that this product delivers a compelling total cost of ownership in that it prevents preactivation, offers a lower syringe snap-in force and a lower activation force for enduser comfort, and mitigates the practice of recapping which helps to provide tamper evidence to customers.
Renowned radiologist Dr Kakarla Subba Rao passes away Renowned radiologist and former Director of Nizam’s Institute of Medical Sciences in Hyderabad Dr Kakarla Subba Rao passed away while undergoing treatment at Krishna Institute of Medical Sciences (KIMS), Secunderabad recently. Dr Rao, 96, was admitted to KIMS a month ago with age-related health complications. Known for his efforts to transform NIMS into a super-speciality hospital, Dr Rao was its first director between 1985 and 1990 and later between 1997 and 2004, before retiring. Born on January 25, 1925, in a middle-
current and future programmes and foster innovation and entrepreneurship across healthcare and agri sectors.
Lumos selects startups in early cancer detection and advanced cancer prognostics Lumos,
a
healthcare
programme,
speed
announced
the
scaling addition
of Onward Assist and ErlySign to its speed scaling programme. The startups were selected after a careful evaluation Dr Kakarla Subba Rao
of
their
technological
strengths
and
business capabilities. Lumos will provide
class agricultural family at Pedamuttevi, a small village in Krishna district, Dr Rao completed his MBBS from Andhra Medical College in 1950 and did his Residency in the US. He was a Professor of Radiology at Albert Einstein College of Medicine, New York, before returning to India in 1985-86.
clinical, technical and business advisory
Juniper Biologics appoints Raman Singh as CEO
advisory services. They have partnered
Singapore-headquartered Juniper Biologics, a science-led healthcare company focusing on researching, developing and commercialising novel therapies, has announced the appointment of celebrated pharmaceutical executive Raman Singh to the role of Chief Executive. Juniper Biologics will be focused on researching, developing and commercialising innovative medications in the areas of oncology, Rare/Orphan Diseases and gene therapy. The company is headquartered in Singapore.
enable startups to hit impressive growth
to help the startups scale and will offer infrastructure
credits
to
help
defray
certain operating expenses. Lumos is a speed scaling ecosystem that helps earlystage healthcare startups grow through timely and powerful business and technical with
premier
healthcare
organisations
to provide valuable mentoring, advisory and business development services to trajectories. The existing repertoire of companies under Lumos are Kronikare, AyuRythm, Alixir, and Raybaby continue to grow with the numerous speed scaling capabilities offered by Lumos.
SIRO Clinpharm partners with ACROSS Global Alliance SIRO Clinpharm has partnered with ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap in the pharmaceutical service provider market. ACROSS is a global alliance of clinical research organizations (CRO’s) also known as Partners along with special service providers known as Qualified Vendors. The partners form the core of the ACROSS organization. SIRO Clinpharm will have the opportunity to provide its core services and expertise in India’s geography.
National Autism Helpline launched in India The National Autism Helpline number has been launched in India. Parents, family members of autistic children can dial India’s National Autism Helpline 9100 181 181 to get free professional guidance, assistance on autism. They can receive free professional advice from expert doctors or therapists regarding their children’s physical growth, behavioural and developmental changes, healthwellness issues and find useful solutions to manage them. This would help the lives of autistic kids better with further inclusion in schools and society at large.
Atal Innovation Mission collaborates with Bayer Government think-tank Niti Aayog’s Atal Innovation Mission (AIM) and German drug and agrochemicals major Bayer partnered to work towards fostering innovation and entrepreneurship across agriculture and healthcare sectors, a statement said. A Statement of Intent (SOI) of strategic partnership between AIM and Bayer was signed. Under the SOI, Bayer will collaborate with AIM to support their
www.indiamedtoday.com
11
NEWS ROUNDUP APACMed announces new Executive Committee in India The
Asia
Pacific
Medical
Technology
Association (APACMed) has announced its new Executive Committee (ExCo) in India. The India ExCo appointments are Pavan Mocherla, MD, Becton Dickinson India, South Asia, as the Chairperson, Meenakshi Nevatia, MD, Stryker India as Vice-Chairperson and Narendra Varde, MD, Roche India & Neighbouring Markets as Vice-Chairperson. Commenting on the new appointments of
the
India
ExCo,
Harjit
Gill,
CEO,
APACMed said, “We are in a period of transformational
change
within
the
healthcare ecosystem, and are delighted to have MedTech industry leaders step forward to contribute and steer India’s healthcare infrastructure and delivery of care through innovative collaborations and engagements with key stakeholders in the system.” Mocherla is the Managing Director of BD where he is closely involved in giving a strategic direction to the organisation’s South Asia operations. Nevatia brings over 20 years of healthcare experience. In her current role as the Managing Director of Stryker, India, Meenakshi is responsible for building Stryker’s business strategy. Varde is the Managing Director for Roche Diagnostics India and Neighboring Markets.
Hester signs agreement with ICAR – IVRI Hester has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute), for acquiring technologies for the production and commercialisation of the following vaccines: Classical Swine Fever Vaccine and Sheep Pox Vaccine.
May 2021
Practo has introduced vernacular language options for its teleconsultation service. This initiative will allow online consultation users to choose a doctor who can speak in their preferred language. Currently, this service covers 15 languages – including
These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for the country’s requirement of Classical Swine Fever Vaccine and Sheep Pox Vaccine.
Hindi, Marathi, Tamil, Kannada and Bengali
The agreements followed with a virtual ceremony that took place on April 7, 2021. The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by the Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.
was launched as a pilot project earlier this
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100 per cent protection. Classical Swine Fever Vaccine has been found to induce protective immunity up to 24 months. Sheep Pox Vaccine has been found to induce protective immunity up to 48 months. The vaccines hope to prevent economic losses in swine and sheep farming in India.
Meenakshi Nevatia, Pavan Mocherla & Narendra Varde
12
Practo launches online consultations in 15 vernacular languages
– with more to be added soon. With this, Practo is one step closer to breaking down access barriers for 200 million unique users in the future. After receiving lakhs of user requests for language-specific features on Practo, this year, with Hindi as the alternate option for users to choose from. During this time, 25 per cent of all online consultations on Practo were conducted in vernacular languages, with Hindi, Tamil, Marathi, and Kannada (in that order) emerging as their preferred language(s) for consultation. Around 67 per cent of all vernacular consultations were from users living in non-metro cities. Remarkably, 65 per cent of all vernacular consults were from users aged 60 and above.
Medtronic Engineering and Innovation Centre opens in Hyderabad Medtronic announced the inauguration of its newly expanded state-of-the-art
The inauguration ceremony Medtronic Engineering and Innovation Center (MEIC) in Hyderabad. The research and development facility was inaugurated by KT Rama Rao, Minister for Municipal Administration and Urban Development, Industries & Commerce, and Information Technology and his team of officials from the Government of Telangana. The 150,000 square feet centre employs engineers currently in the areas of software development and testing, test automation, mechanical design, analysis and hardware. With this expansion, MEIC aims to leverage the sizeable pool of diverse and skilled talent in India to continue its pioneering work in the medical technology space and add further to Medtronic’s 150+ patents and 400+ IP disclosures globally that MEIC has been a part of.
J Mitra launches COVID-19 neutralising antibody test kit J Mitra & Company has launched India’s first COVID-19 Neutralizing Antibody Microlisa Elisa Test. The test kit has cleared all government parameters and received all necessary approvals, including Drug Controller General of India
(DCGI) and successful product validation. Virus neutralisation remains the gold standard for determining antibody efficacy. COVID-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralising antibodies against SARS-CoV-2, the virus that causes COVID-19. The test kit will help to highlight the efficacy of the vaccines on the human body and the development of the antibodies to fight the virus and help identify potential plasma donors. The test kit has high sensitivity (> 95 per cent) and Specificity (100 per cent). The test identifies individuals who have had recent or prior infection with SARSCoV-2. Detection of neutralising antibodies helps us identify its significance for patients as we continue the fight against COVID-19.
Dr Harsh Vardhan launches IHIP The Union Minister of Health & Family Welfare, Dr Harsh Vardhan virtually launched the Integrated Health Information Platform (IHIP) in New Delhi, in the presence of Ashwini Kumar Choubey, Minister of State for Health and
Family Welfare. Chief Minister Shri Tirath Singh Rawat (Uttarkhand) was also present digitally. The IHIP is the next generation highly refined version of the presently used Integrated Disease Surveillance Programme (IDSP). The virtual event was attended by health ministers of various states including Balbir Singh Sidhu (Punjab), Alexander Laloo Hek (Meghalaya), Dr K Sudhakar (Karnataka), Dr Prabhuram Choudhary (Madhya Pradesh), Jai Pratap Singh (Uttar Pradesh), Etela Rajendra (Telangana), TS Singh Deo (Chhattisgarh), Dr R Lalthangliana (Mizoram) and S Pangnyu Phom (Nagaland).
Piramal acquires Hemmo Pharma for Rs775 crore Piramal Pharma’s Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), has agreed to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront consideration of Rs 775 crores and earn-outs linked to the achievement of milestones. Hemmo is one of India’s largest manufacturers of synthetic peptides with a legacy of more than 38 years in
www.indiamedtoday.com
13
NEWS ROUNDUP business supplying peptide products and custom peptide synthesis. Hemmo has R&D capabilities and a world-class GMP manufacturing facility that has been inspected and deemed compliant by the US, the EU and Asian regulatory agencies. The company has strong expertise in both solution-phase and solid-phase synthesis of peptides, the announcement said.
Siemens Healthineers announces upcoming ‘Innovation Hub’ in Bengaluru Siemens Healthineers announced the winner of their architecture competition for the upcoming ‘Innovation Hub’ in Bengaluru. The company invited six architecture firms to participate in a contest to design a campus that combines the existing research and development centre and a state-of-the-
art manufacturing facility for entry-level medical imaging products. The campus will also house the Indian sales headquarters and is to be set up over the next five years with an investment of Rs 1,300 crores.
Fortis Healthcare appoints Joerg Ayrle as additional director Fortis Healthcare said its board has approved the appointment of Joerg Ayrle as an additional director (non-executive) of the company, with immediate effect. He was appointed as the group chief financial officer (CFO) of IHH Healthcare Berhad on February 1, 2021, Fortis Healthcare said in a filing to the BSE. With a wealth of international experience from the US, Germany, Singapore, China and Thailand, he will be responsible for providing financial leadership and strategic guidance for IHH and its operations and
‘Innovation Hub’ Siemens Healthineers, Bangalore
14
May 2021
Joerg Ayrle the business plan development, it added. Before joining IHH, Ayrle was the group CFO of Thai Union Group and steered the company’s financial transformation journey, the filing said.
APPROACH
Lending a Helping Hand How Corporates to NGOs and even small startups are assisting in the fight against COVID-19
about people dying on roads gasping for oxygen while their relatives made a frantic effort to locate oxygen cylinders. Though the government tried its best it was too little and too late and the entire country was reeling under a catastrophe. Though foreign countries chipped in with BiPAP machines, oxygen concentrators
(OC),
the
distribution
mechanism was a major hurdle for the administration of various states. This is where NGOs, individuals and organisations joined hands with the ministry to help the needy with COVID relief materials. Even special mention can be made of several crowd funding initiatives by startups and NGOs who have come forward to fight the deadly pandemic. Initiatives by organisations • Recently India did manage to overcome the
the
Indian
start-up
community joined hands to set up
first wave of COVID-19 pandemic with
ACT Grants to help the country face
stringent measures in place. However,
the crisis. Amazon India tied up with
the
everyone
ACT Grants, Temasek Foundation, Pune
unaware and it dealt a death blow
Platform for COVID-19 Response (PPCR)
to the people with the healthcare
and other partners to airlift over 8,000
infrastructure totally overburdened and
oxygen concentrators and 500 BiPAP
collapsed. The country already grappling
machines from Singapore.
for better infrastructure saw a surge in
• Food
second
wave
caught
oxygen demand besides shortage of medicines and vaccines.
delivery
and
restaurant
aggregator Zomato has rolled out a new feature on Apple and Android devices
The second wave has seen a sudden
to enable users to mark food orders as
demand of oxygen as the mutant
‘COVID-19 emergency’. It has partnered
virus turned out to be more fatal than
with logistics firm Delhivery to address
previous occasions. There were news
the acute medical oxygen shortage.
www.indiamedtoday.com
15
APPROACH •
Paytm under the #OxygenForIndia
providing
cash
Concentrators (OCs) and for the same
COVID-19 crisis. GiveIndia has ramped
the company has already raised Rs 5
its effort to help people suffering from
crore from citizens for the initiative and
the
has matched rupee for rupee making
fund has been re-initiated to provide
it Rs 10 crore. The Paytm Foundation
life-saving equipment such as oxygen
is
start-ups,
concentrators and cylinder, help with
organisations and enterprises to source
supplies of N95 Masks, PPE Kits, 3ply
OCs from the international market.
masks, bedsheets, hand sanitisers and
also
app,
21,000
supporting
has
campaign
other
App,
the
telemedicine
started
a
crowdfunding
across
several
platforms
pandemic.
The
covid
response
other resources for critical patients and healthcare workers at hospitals and Covid care centres.
to help hospitals across the country
•
get
oxygen
to donate food to families struggling
concentrators. Swasth along with ACT
with hunger in COVID-19's second wave
Grants have launched a website called
and help women in need to have a
liferesources.in.
hygienic menstrual cycle by providing
immediate
• Similarly, Hemkunt
access
to
Gurgaon-based
Foundation
is
NGO
distributing
oxygen cylinders to COVID-19 patients through its network of volunteers. The NGO has supplied more than 1,000 oxygen cylinders to needy patients. It
May 2021
is
assistance to families hit hardest by
airlifted
• Swasth
16
• GiveIndia
Oxygen
initiative
The funds raised will be allocated
them with reusable sanitary napkins. GiveIndia's COVID funds will also be used to increase the vaccination and testing capacity across the country, in addition to providing cash relief for the families of the deceased.
has also started a 'drive thru' scheme
• Additionally,
for patients to come to their office and
brands like Google, Flipkart, Amazon
corporations
and
inhale oxygen from the cylinders free-
have also partnered with GiveIndia to
of-cost.
provide cash assistance to families hit
hardest by the crisis to help with their everyday expenses.
•
• NGO Milaap is running food support programmes to covid patients across Delhi where 1000 food packets are being provided to the homeless people daily. Democracy People Foundation’s self-funded mission called 'Mission Oxygen' help hospitals across the country get immediate access to oxygen concentrators. As the demand grew, the NGO has now launched a crowdfunding initiative on Ketto to raise Rs 5 crore for the cause.
and Medium sized Enterprises) have
• KVN Foundation has launched Mission Million Air and is working to supply free oxygen concentrators to the needy until they find a hospital bed, get access to doctors, or recover completely. Starting in Bengaluru and Mumbai, the initiative plans to add more cities as they work to procure oxygen concentrators in bulk.
by individually entering different PIN
• Homegrown mapping platform MapMyIndia is working to make it easier to track vehicles carrying oxygen, vaccines and other medical infrastructure transport. Free GPS tracking systems will be installed in such vehicles in the country.
and critical medical equipment, provide
• Jeeva Rakshak Foundation, a nonprofit organisation, has joined hands with VMEDO, specialists in emergency healthcare services primarily ambulance services.
cylinders and concentrators.
FICCI, and its partner association
BVMW (German Association of Small extended their support by successfully procuring 1500 oxygen concentrators for
private
entities
in
the
Indian
Healthcare industry, to combat the current crisis. •
Adding to it, Paytm announced the
launch of COVID-19 Vaccine Finder on its Mini App store. The platform helps citizens to check the availability of vaccination slots for a specific date codes or district details along with age group (18+ or 45+). •
Recently, Wells Fargo & Company
has committed more than $3 million (Rs 25 crores) through non-governmental organisations
to
increase
hospital
capacity, supply oxygen concentrators emergency transportation, and support healthcare workers. • HealthCube under the initiative called OxygenForIndia will now enable the distribution of medical oxygen
Contribution
from
organisations
in
large numbers will help India fight the pandemic in a new way.
www.indiamedtoday.com
17
IMPACT
Diagnostics Vs COVID-19: The David versus Goliath Story Insight into the contribution made by the Indian diagnostics industry amidst the COVID-19 pandemic
The year 2020 has been tumultuous for the healthcare industry across the world on account of the corona pandemic. And if that wasn’t enough, the second wave of COVID-19 has had a devastating effect on the healthcare industry in general, and the diagnostics industry in particular.
The First Wave Story
Jatin Mahajan, Managing Director, J Mitra & Company
18
May 2021
When corona hit us in December 2019-January2020, the world had no idea about the disease. But the Indian diagnostics industry was quick to rise to the occasion and develop tests based on different technologies – Antibody tests, antigen tests, RT-PCR tests, amongst others. This was remarkable, especially in the backdrop of a scenario where foreign-made tests were drawing a lot of flak on account of their accuracy and sensitivity. India’s strategy to combat COVID-19 was — Test-Track-Treat. These locally developed test kits did a real yeoman service when there was a real scarcity of test kits in the market, and India was finding it difficult to attain the testing momentum that was required to counter the threat of COVID-19. The Indian test kit manufacturers, driven by their extensive R&D, were quick to
• The masses became extremely complacent, especially after the launch of the two vaccines in India. People assumed that the worst is over, and disregarded all caution and standard operating procedures related to masks, social distancing and avoiding crowded areas and possible infections. People adopted a lifestyle like what they had been practising in October-November 2019 before the pandemic • The central and state governments ruefully misjudged their preparedness and the impact of the mutated virus. The restrictions were imposed too less, and too late, and this led to the massive spread of the virus and more and more people getting affected.
come up with extremely potent test solutions in all the above-mentioned technologies. It was this quick and effective action of the Indian diagnostics manufacturers that arrested the spread of the coronavirus in the country. And most of these test solutions were much better on various parameters as compared to their foreign counterparts. Most Indian COVID-19 test kit manufacturers were dependent on foreign suppliers for their raw materials, and thus production was severely impacted. But the Indian manufacturers quickly figured out alternate sources for the raw material to mitigate the loss of production. India’s delivery of the diagnostics story is also a remarkable one and an example of leadership and planning at various levels of the diagnostics and policy ecosystem. Both the government and the private sector came together to effectively tackle the pandemic. The government ensured that all tests were Aadhaar-linked, and thus properly traceable – thus ensuring proper management of COVID-19 positive patients. The hospitals and diagnostic chains came forward very effectively
to ensure that all precautions were taken to mitigate risks and at the same time provide an environment for quick, convenient, effective and in many cases door-step collection of sample and online reportage – enabling more and more people to come forward and get tested as and when they demonstrated covid-like symptoms. While everything may have seemed very normal to the end-users, the effective mechanism of collection, timely submission to the laboratories (especially in the case of central lab systems), testing and reportage was perfected to an art.
The second Wave and its Aftermath
But the diagnostics industry has risen to the challenge, and all diagnostics teams are working overtime and multiple shifts to cater to the increased testing demands. There are currently no numbers available to provide a clear indication of the increased percentage, but I probably would not be wrong if I say that they have increased 10 times what it was in February. There are lines outside testing laboratories, and there is a wait time of three to four days just to get yourself tested. In many cases, the test results are being delayed for a couple of days because there are not enough machines and technically qualified staff to cater for this unimaginable demand. But this failing is not of the diagnostics industry because these are unprecedented and unimaginable demands, and the faults lie elsewhere.
The 2nd wave of the corona pandemic in India paints a very sordid story of the overall scenario in India. We were completely caught unaware and unprepared to handle the situation as a country. We failed on three major counts
COVID-19 testing is being accorded priority over all other diagnostics to ensure that test results are provided at the earliest, both to dispel anxiety in case of a negative report and to mitigate chances of further spreading in the case of positive reports.
• We were completely unaware and unprepared for the second wave. As a country, we did not see the mutated virus spreading until it was too late and massive damage and loss of lives had already taken place
The Indian diagnostics segment has truly demonstrated sheer leadership in tackling the corona pandemic and bringing diagnostics to the very forefront of the fight against the pandemic.
www.indiamedtoday.com
19
COVERSTORY
Anatomy of Oxygen Crisis in India
Exploring the extent and cause of oxygen crisis that led to avoidabledeath toll during the second COVID-19 wave in India M Neelam Kachhap 20
May 2021
O
n April 21, 2021, India woke up to an unprecedented scene. A 67-year-old doyen of medical institute in Delhi had lost 25 critically ill patients due to oxygen shortage. Shortly after, other hospitals in Delhi also sent out SOS for oxygen as they did not have enough supply to help their patients. In the following days, reports of
patients dying due to a shortage of oxygen emerged from different parts of India. Many PILs were filed at different high courts asking the government to expedite the supply of oxygen to hospitals. Long queues of empty cylinders and people waiting outside hospitals flash across TV screens every day, bringing to light, the lack of facilities and the glaring gaps in governments preparedness to tackle the pandemic. The second wave of COVID-19 has crippled the existing healthcare infrastructure and indented the hospitals and healthcare workers in India. The avoidable death due to the shortage of Liquid Medical Oxygen (LMO) has been one of the most discerning pictures during this second wave of the pandemic.
Second Set-back India has been hit hard with the second wave of COVID-19 pandemic- a covid storm. The WHO said that the situation in India is beyond heartbreaking. “Globally, the COVID-19 pandemic continues to intensify. To put it in perspective, there were almost as many cases globally last week as in the first five months of the
www.indiamedtoday.com
21
COVERSTORY
pandemic. Many countries are still
Dr Balakrishna GK, HOD & Senior
experiencing
transmission,
Consultant - Internal Medicine, BGS
and the situation in India is beyond
Gleneagles Global Hospital said, “The
heart-breaking,” Dr Tedros Adhanom
current
Ghebreyesus,
is highly virulent, which is rapidly
intense
Director-General,
WHO
said during a press briefing.
“The LMO cylinders are cheaper and provide good quality oxygen, with a steady supply,” Sameer Mehta, Director – Projects, Hosmac India
What is more discerning is the number
highest single-day cases of COVID-19. The data sourced from covid19india. org, an independent aggregator of daily figures from state health departments showed more than four lakh cases and 3,464 new deaths on the day.
of patients requiring oxygen support. to
the
National
Clinical
COVID-19 Registry 54.5 per cent or more than one out of two people admitted in hospitals, need oxygen support during the second COVID-19 wave as compared to 41.5 per cent in
22
May 2021
with
mutant
strains
spreading to a larger population, at
On April 30, 2021, India recorded the
According
wave
once. In addition, 1-2 per cent of these patients develop SARS (Severe Acute Respiratory Syndrome COV 2). An unexpected sudden increase in the number of cases with limited availability of infrastructure is the main reason for increased demand for oxygen.” He said that the current wave with mutant strains has severely affected a large number of the younger population. “In the first wave, timely preventive measures helped, to a certain extent, in reducing the burden of oxygen support,” he adds.
the first wave. Oxygen continues to be
Procuring oxygen
a critical factor in the management of
There are two ways in which oxygen
COVID-19 during the second wave.
is supplied to the patients. One is an
onsite-oxygen concentrator at hospitals
“Currently, we are not facing an oxygen
that filters atmospheric oxygen and
shortage at any of our Aster Hospitals.
collects it in tanks for the hospital to
We are working closely with the district
use later. Second, is the more popular
and state administration and monitoring
and prevalent practice of hiring high-
the situation in real-time, and all help is
pressure LMO cylinders. “The LMO
being provided by the state authorities,”
cylinders are cheaper and provide good
an Aster DM Healthcare spokesperson
quality oxygen, with a steady supply,”
said.
says Sameer Mehta, Director – Projects, Hosmac India. Mehta, an expert in
“Generally, you will find a very tall
“The situation in India is beyond heartbreaking,”
medical
and
white tank connected to pipes at the
engineering has worked on more than
bottom and surrounded by a fence
500 hospital projects across India.
around the back of the hospital. This
“If the hospital is in a remote area,
Dr Tedros Adhanom Ghebreyesus, Director-General, WHO
Ideally, a hospital is required to have a
where LMO supply is not available then
minimum of one day’s supply on hand
we recommend oxygen concentrators,”
and one normal day’s back up supply
Mehta adds. He further explains that
in case the main system fails to sustain
there has never been a challenge with
their patients giving them time to fix
LMO before as hospitals map their
or replace the primary oxygen supply,”
consumption requirements and vendors
explains Ayanabh Debgupta, Co-founder
refill or replace cylinders conveniently.
& Group President, Medica Hospitals.
planning,
architecture
tank contains tonnes of liquid oxygen.
Aster
Hospitals,
a
group
of
large
corporate hospitals in South India has
e
said that it has managed the situation
specialised equipment and checks that
further
explains
that
there
so far.
need to be in place for the consumption
www.indiamedtoday.com
are
23
COVERSTORY of LMO at hospitals. “Liquid oxygen
pronounced
boils at normal temperatures, that’s why
compared to last year consumption of
it is always transported in cryogenic
oxygen is higher at hospitals. We have
tanks and cylinders. Oxygen is highly
never seen a situation like this before
inflammable so transporting the gas is
where hospitals had to send out SOS for
very challenging,” says Debgupta.
oxygen. This is unprecedented,” Mehta
When oxygen is at room temperature the
gaseous
phase
is
piped
at
a
regulated pressure into the hospital building where it is measured and the pressure regulated before being piped throughout the building. At the entry point, there must be a shut-off valve and a pressure sensing alarm, he says.
this
time
around.
As
laments.
Short-sighted Management Five days before the oxygen crisis became
catastrophic
in
late
April
2021, the Empowered Group 2 (EG2, a group formed by the PMO comprising
also
officials from different ministries and
specialised. “Oxygen follows through
experts), met to review the availability
a special kind of copper pipe that has
of essential medical equipment and
to be brazed together in a nitrogen
oxygen. According to a release from
atmosphere. These oxygen pipes in the
the Health Ministry, they discussed the
walls and ceilings of the hospital deliver
rising demand for oxygen and were
The
pipeline
for
oxygen
is
pure hydrated oxygen to the outlets on the wall near each bed. Before the oxygen gets to those outlets it is valved, gauged and alarmed one or two more times,” Debgupta explains.
Use of LMO Talking about the use of LMO at hospitals Mehta says, “Commonly, use of oxygen is minimal at hospitals, around 5-6 litres per min per bed, but not all beds use oxygen at the same time. If 10 per cent of non-critical care beds in a 100-bed hospital are using oxygen then one can estimate about 50-60l per min per bed.” The use of oxygen at hospitals has surged
due
to
the
unprecedented
number of patients admitting with the disease that requires management with oxygen. “In mid-march, we had five Covid-19 patients. However, in April 2021 almost all our beds, 250 of them were full and we had patients waiting outside for beds,” Debgupta explains. “Criticality of the disease is more
24
May 2021
“In mid-march, we had five Covid-19 patients; by April 2021 almost all our beds, 250 of them were full and we had patients waiting outside for beds” Ayanabh Debgupta, Co-founder & Group President, Medica Hospitals
“An unexpected sudden increase in the number of cases with limited availability of infrastructure is the main reason for increased demand for oxygen.” Dr Balakrishna GK, HOD & Senior Consultant - Internal Medicine, BGS Gleneagles Global Hospital
aware of the increasing demand for
capacity. “Along with the ramped up
medical oxygen, especially from the
production of the oxygen manufacturing
12 states with a high burden of active
units and the surplus stocks available
COVID cases– Maharashtra, Madhya
(50,000 MTs), the present availability of
Pradesh, Gujarat, Uttar Pradesh, Delhi,
oxygen is sufficient,” said a ministry of
Chhattisgarh, Karnataka, Kerala, Tamil
the health press release. However, they
Nadu, Punjab, Haryana and Rajasthan.
were proved to be wrong.
While the demand in Maharashtra was not expected to go beyond the available production capacity of the state, states like Madhya Pradesh did not have any production capacity to meet their demand for medical oxygen, the group noted. According to official figures, India has a daily production capacity of 7127 MT of oxygen per day. On 12, April 2021, the medical oxygen consumption in the country was 3842 MTs, which was only 54 per cent of the daily production
The Hindu reported that six people died at a private hospital, Neelkanth at Amritsar, Punjab when they did not receive proper oxygen. In another incident, at least 24 COVID-19 patients in Nashik city died when the hospital’s oxygen supply ran out because a tanker refilling it suffered a leak and had to be shut for maintenance. 25 patients at Delhi’s Jaipur Golden hospital died late night April 23, allegedly due to the shortage of oxygen, according to a
hospital
statement.
Delhi’s
Batra
hospital said in a statement that eight of its patients, including a doctor, passed away on Saturday 29 April due to lack of oxygen. Similar stories were reported from Gujarat, Uttar Pradesh and Karnataka. According
to
the
Johns
Hopkins
University Center for Systems Science and
Engineering
(JHU
CSSE)
data,
an average of 3187 people died of COVID-19 in a week in India between April 14-May 1, 2021. However, there is no official figure yet listing deaths due to oxygen shortage in India.
Portable Oxygen Concentrators Among a large number of COVID-19 patients who are at home and in need of oxygen therapy has thrown the spotlight on smaller devices. An oxygen concentrator is a device that filters the air around us to supply only oxygen to the patients through a cannula, oxygen masks or nasal tubes.
www.indiamedtoday.com
25
COVERSTORY However, its use is limited to patients
bridge this surging demand and supply
with moderate symptoms.
gap.
“Oxygen concentrators can be used only
Oxygen manufacturers like Inox Air
in moderate cases of COVID-19 when
Products, Linde India, Goyal M G Gases,
the patient experiences drop in oxygen
National Oxygen and Taiyo Nippon
levels, where the oxygen requirement
Sanso Corporation have said that they
is a maximum of 5 litres per minute,”
have
explained
Prof
Sanyogita
Naik,
Professor and Head of Department Anaesthesia, BJ Medical College, Pune. Speaking at a webinar on COVID-19 organised by PIB the professor added that oxygen concentrators are also very useful for patients experiencing postCOVID complications which necessitate oxygen
therapy.
Depending
upon
the capacity, O2 Concentrators cost upwards of Rs 30,000.
increased
production
capacity
but the transport of oxygen is still a challenge. However, most experts we spoke to said that the production capacity of oxygen is not the problem, but its distribution and transport were the bottlenecks. “India can produce LMO for its domestic consumption, however, its distribution and transport are the major bottlenecks that need to be streamlined,” said Mehta. The Indian Railways’ Oxygen Express is
Way Out
trying to ease this problem. Trains have
As the news of medical oxygen shortage
via Nagpur to Nashik and Lucknow to
spread, the government along with
Bokaro and back with a total of 10
the corporate sector came into action.
containers having nearly 150 tonnes of
In addition, the government of other
liquid oxygen have been carried so far
countries mobilised instruments to help
the ministry said on April 24.
26
May 2021
run between Mumbai to Visakhapatnam
“Oxygen concentrators can be used only in moderate cases of COVID-19” Prof Sanyogita Naik, Professor and Head of Department Anaesthesia, BJ Medical College
In addition, PM CARES Fund has given in-principle approval for the allocation of funds for the installation of 551 dedicated Pressure Swing Adsorption
Oxygen Requirement for
50 patients
(PSA) Medical Oxygen Generation Plants inside public health facilities in the country. Steel plants in both the public and
1 patient requires
10Lpm
private sector are striving hard to supply liquid oxygen to different states. 2894 tonnes of oxygen was dispatched to different states on 24 April by steel plants in the public and private sector
10Lpm X 50 X 1440 minutes =
720000 litres in a day
as against 1500-1700 metric tonnes per day a week earlier. Steel plants are also filling oxygen cylinders and supplying them to the public and private hospitals in Orissa and Jharkhand. Further, the government has imported 20 cryogenic tankers of 10 MT and 20 MT capacities and allocated them to states, addressing the shortage of
One D type cylinder has about
7000 litres 102
So cylinders per day
oxygen tankers in the country. All these efforts are welcome but these will dwarf in comparison to the rising Covid-19 infections. If India can reduce the daily Covid-19 cases then
With back-up
120 cylinders per day would be required
the oxygen crisis will dissipate but with the current measures this looks like a distant dream; blaring alarm for even bigger oxygen crisis in coming days.
Source: Senior Engineer, Multispeciality Hospital
www.indiamedtoday.com
27
FEATURE
Distressed Diagnostic Labs A look into the burdened COVID-19 testing labs and how they work against time to fulfil mounting demand
Diagnostic laboratories are facing unprecedented challenges to help fight the COVID pandemic on one hand and the other sustaining themselves financially due to the price cap by the government. Big players have however somehow succeeded with many adopting technology as a means to survive. Before travelling to my native place from Mumbai in April 2021, I came to know from certain government websites, airline portals and certain apps that one has to undergo compulsory RT-PCR test with a handy negative report to travel. I was caught unaware of how bad the situation was on the ground when my family reached the door of a private laboratory to undergo the RT PCR test. I was shocked to see a huge number of people in the queue having COVID like symptoms on one hand and others trying to leave the city as the lockdown deadline was nearing. The situation was so bad that upon enquiring I was told that many people were standing in the queue since morning only to have their samples taken by late afternoon. With a raging second wave of COVID, the staff seemed helpless, overburdened and in chaos.
Pandemic Impact After the first wave of the pandemic, many were caught unaware of the second wave which resulted in a catastrophic situation. Overburdened diagnostics labs, staff shortage,
28
May 2021
Dr Abhik Banerjee Chief of Quality, Senior Consultant- Pathology, Nodal Officer, COVID 19 Cell, Suraksha Diagnostics lockdown protocols all lead to delay in handing over the reports which resulted in late medication for COVID positive patients and ultimately deaths for many. (As on May 1, 2021, India reported 3,92,603 new COVID-19 cases and 3,673 deaths till 11.15 p.m ) To mitigate the crisis, laboratories across India undertook certain measures. Maintaining the safety of staff, running the labs during the pandemic were all looked upon by the management so that people were less inconvenienced. Kolkata-based
Suraksha
diagnostics,
Dinesh Chauhan, CEO, CORE Diagnostics like many other labs, faced fewer walkin patients on one hand during the pandemic and subsequent lockdown while on the other the labs were overburdened with the challenge of testing the samples in huge numbers. Dr Abhik Banerjee, Chief of Quality, Senior Consultant- Pathology, Nodal Officer, COVID 19 Cell, Suraksha Diagnostics says, “Several areas of diagnostic healthcare have been impacted due to this pandemic. One has to maintain the usual lab and centre
operation, the emergency services as far as possible despite the threat to the safety of customers and its staff. Secondly, the financial impact was huge given the drastic reduction in revenue generated from routine test segments and thirdly has been a shift in the overall environment of the laboratories due to the increased demand for COVID-19 testing.”
Challenges Galore Sharing similar challenges, Dr Harish Pillai, CEO – Aster India, Aster DM Healthcare, says that there was a challenge to collect samples and provide reports on time along with ensuring service standards were maintained. Dr Pillai adds, “The unavailability of manpower due to quarantine measures, burn out of home collection services, surge in the prices of PPE material, increased lead time for delivery of diagnostic equipment from two to three weeks in normalcy changed to seven to eight week time, the unavailability of consumables like sodium citrate tubes, delays in imported kits due to global lockdown, etc. were some of the other challenges faced.”
Dr Harish Pillai, CEO – Aster India, Aster DM Healthcare
However, according to him, processes were altered to tackle the unprecedented load and besides a fully equipped pathology reference laboratory, a
team of highly trained lab technicians followed all requisite processes to not only manage the load but ensured the quality of services provided. Dr Kamlesh Kumar Patel, Director of Rajasthan-based Livepath Diagnostic Laboratory shared similar views of the overburdened system which arose due to the unprecedented situation. Dr Patel opines, “Keeping the price of the test affordable while maintaining quality standards was extremely challenging.” The private diagnostics sector played a crucial role in expanding and strengthening the testing capacity to meet the recurring surge. Cost pressure is another major challenge being faced by the diagnostics labs. Dinesh Chauhan, CEO, CORE Diagnostics opines that there is still an existing challenge for certified labs to conduct tests at the set price given the rise in the cost of consumables and supply chain shortages. Furthermore, with prepayments becoming a norm for suppliers and deferred payments from hospitals (both private and government), there is indeed a cost pressure for diagnostic companies. So what has become the new norm for the diagnostic labs to overcome the above-mentioned challenges? It may be noted that smaller labs ceased to
www.indiamedtoday.com
29
FEATURE exist in many places and bigger labs could afford to tweak their strategies to somehow manage to sustain themselves.
information management system has been the norm since the company's incubation stage.”
The New Norm
The Tech Push
Many pathologists are working remotely through digital pathology solutions to avoid challenges related to physically being in the labs/hospitals.
The world has witnessed phenomenal technological innovation in the healthcare space and diagnostics labs have been able to utilise the right opportunity to evolve in this space. Automation in healthcare has helped diagnostics labs mitigate the crisis to a certain extent.
According to Chauhan from Core Diagnostics, “To access the best pathologists globally, we have been scanning and getting slides reviewed wherever needed. Another significant change we saw was the adoption of home collection. The surging panic and need for stabilisation helped the industry to re-focus on the importance of the home collection. Furthermore, early detection and accurate diagnostics are important for labs as screening becomes the new normal.” Suraksha Diagnostics has been able to reestablish the importance of laboratory medicine specialists. According to Dr Banerjee, the footprint is surely going to stay forever. The development of new molecular biology setups and scaling up of existing infrastructure, have been noticed at a pace that was never imagined before. The customer
30
May 2021
Dr Kamlesh Patel, Director Livepath Diagnostic Laboratory relationship management team has observed a dramatic increase in phone calls requesting for home collection and inquiring about the availability of tests like CRP, D-DIMER, IL6 etc. In addition, 24/7 operations have become the new norm adopted by Mapmygenome. Says Anu Acharya, CEO, Mapmygenome, “Mapping the workflows into our secure laboratory
Aster DM Healthcare adopted highend technological options by the molecular department, with lesser TAT like the Abbot Id & Genexpert. Mobile applications for quick bookings of the service by the patients were introduced which also enabled them to track the report status. Even automation in admin workflow helped Aster DM Healthcare overcome the challenge somewhat. While the diagnostic industry was already on the verge of technological advancements, the crisis accelerated the pace. Right from booking tests, sample collection, to reporting- everything is now fully automated. CORE
Diagnostics
not
only
started
working remotely but many of the pathologists were examining the dayto-day slides while physically being in the lab. Chauhan says, “Data has always been of utmost importance to us ever since we started, and we have state-ofart security for storing samples after analysing them. Shortly, we intend to set up an R&D facility that will solely focus on bringing low-cost, reliable, and easy-to-use in-house testing kits.” MapmyGenome’s Viral Transport Medium ensured that there is no lab contamination – and any virus in COVID samples is killed in CoviSafe kits, while its genetic structure remains intact for testing purposes. The entire workflow is mapped into secure LIMS.
several blood tests to help understand antibodies and other COVID-related parameters. It has also been involved in seroprevalence studies with RT PCR, antibodies, T cell markers etc.
The future The year 2020 was a hectic year for diagnostic labs with staff and management on the tenterhooks as with rising cases a large number of samples were required to be analysed within a short period. With COVID-19 showing no signs of abatement and subsequent waves coming back, diagnostic labs
R&D in Full Force
Acharya opines, “The pandemic has increased people's awareness towards preventive healthcare. Predictive testing is rapidly seeing more takers. For healthcare providers and their customers, now is the best time to shift to a personalised, predictive, preventive, and participatory model.” Patel foresees a lot of growth in the online healthcare space. During the pandemic, Livepath Laboratory has identified the need and growth potential of online healthcare facilities and launched an online medical aggregator platform. Dr Banerjee is optimistic about the future of diagnostic labs and predicts a definite increase in predictive health check-up in the coming days. “No doubt, the laboratory industry is better prepared now to handle challenges and days are going to be brighter than ever before,” he opines.
Many labs have taken up new and innovative test methods. With the pandemic raging across the country, Mapmygenome’s R&D team turned its focus on developing two tests — an RTPCR based diagnostic test for COVID-19 and a predictive genomics solution Genomepatri Immunity. The combined teamwork of Mapmygenome employees helped to develop the COVID testing workflow and to gain NABL and ICMR approvals. In September, Mapmygenome built a second ICMR approved lab at GMR Hyderabad International Airport to help screen both departing and arriving passengers. The company added
have been able to gauge the right sentiments.
Anu Acharya CEO Mapmygenome India
As predicted that COVID-19 is here to stay forever with waves coming in at different times, diagnostics labs will be under tremendous pressure till new strategies are adopted. For big laboratories implementing the right strategies will work in favour of them but for smaller labs, it will be a tough road ahead to sustain. Only time will say what the future beholds.
www.indiamedtoday.com
31
PULSE
COVID-19 Second Wave in India After early success, India's daily COVID infections have surpassed the US and Brazil. Why?
Rajib Dasgupta, Chairperson, Centre of Social Medicine and Community Health, Jawaharlal Nehru University
India is in the grip of a massive second wave of COVID-19 infections, surpassing even the US and Brazil in terms of new daily infections. The current spike came after a brief lull: daily new cases had fallen from 97,000 new cases per day in September 2020 to around 10,000 per day in January 2021. However, from the end of February, daily new cases began to rise sharply again, passing 100,000 a day, and now crossing the 200,000 mark. Night curfews and weekend lockdowns have been reinstated in some states, such as Maharasthra (including the financial capital Mumbai). Health services and crematoriums are being overwhelmed, COVID test kits are in short supply, and wait times for results are increasing.
32
May 2021
How has the pandemic been spreading? Residents in slum areas and those without their household toilet have been worst affected, implying poor sanitation and close living have contributed to the spread. One word that has dominated discussions about why cases have increased again is laaparavaahee (in Hindi), or negligence. The negligence is made out to be the fault of individuals not wearing masks and social distancing, but that is only part of the story. Negligence can be seen in the nearcomplete lack of regulation and its implementation wherever regulations did exist across workplaces and other public spaces. Religious, social and
political congregations contributed directly through super-spreader events, but this still doesn’t explain the huge rise in cases. The second wave in India also coincides with the spread of the UK variant. A recent report found 81 per cent of the latest 401 samples sent by the state of Punjab for genome sequencing were found to be the UK variant. Studies have found this variant might be more capable of evading our immune systems, meaning there’s a greater chance previously infected people could be reinfected and immunised people could be infected. A new double mutation is also circulating in India, and this too could be contributing to the rise in cases.
Low fatality rate? In the first phase of the pandemic, India was lauded for its low COVID death rate (case fatality rate) of about 1.5 per cent. However, The Lancet cautioned about the “dangers of false optimism” in its September 26 editorial on the Indian situation. In a pandemic situation, the public health approach is usually to attribute a death with complex causes as being caused by the disease in question. In April 2020, the World Health Organization clarified how COVID deaths should be counted: Death due to COVID-19 is defined for surveillance purposes as a death resulting from a clinically compatible illness, in a probable or confirmed COVID-19 case, unless there is a clear alternative cause of death that cannot be related to COVID disease (e.g. trauma). It is unclear the extent to which the health authorities across the states of India were complying with this. Many states have set up expert committees to re-examine and verify COVID-19 deaths after coming under criticism that reported death rates were not accurate. Many states made corrections in mortality figures, and the full extent of undercounting is being actively researched.
District-level mortality data, both in the first wave as well as in the current wave, confirm that the global case fatality rate of 3.4 per cent was breached in several districts such as Maharashtra, Punjab and Gujarat. Case fatality rates in some of the worst-affected districts were above 5 per cent, similar to the 5 per cent mortality level in the US.
What are the challenges this time? A majority of the cases and deaths (81 per cent) are being reported from ten (of 28) states, including Punjab and Maharashtra. Five states (Maharashtra, Chhattisgarh, Karnataka, Uttar Pradesh and Kerala) account for more than 70 per cent of active cases. But the infection seems to have moved out of bigger cities to smaller towns and suburbs with less health infrastructure. Last year, the government’s pandemic control strategy included government staff from all departments (including non-health departments) contributing to COVID control activities, but these workers have now been moved back to their departments. This is likely to have an effect on testing, tracing and treating COVID cases. And healthcare workers now have a vaccine rollout to contend with, as well as caring for the sick.
What now? In early March the government declared we were in the endgame of the pandemic in India. But their optimism was premature.
Despite an impressive 100 million-plus immunisations, barely 1 per cent of the country’s population is currently protected with two doses of the vaccine. The India Task Force is worried that monthly vaccine supplies at the current capacity of 70 million to 80 million doses per month would “fall short by half” for the target of 150 million doses per month. Strict, widespread lockdowns we have seen elsewhere in the world are not appropriate for all parts of India given their effect on the working poor. Until wider vaccination coverage is achieved, local containment measures will have to be strengthened. This includes strict perimeter control to ensure there is no movement of people in or out of zones with local outbreaks, intensive house-to-house surveillance to ensure compliance with stay-at-home orders where they are in place, contact tracing, and widespread testing. It should go without saying large congregations such as political rallies and religious festivals should not be taking place, and yet they have been. Strong leadership and decentralised strategies with a focus on local restrictions is what we need until we can get more vaccines into people’s arms.
This article is republished from The Conversation under a Creative Commons license.
www.indiamedtoday.com
33
REPORT
Double-lung transplant after COVID-19 First case in Canada on a patient whose lungs were irreparably damaged by COVID-19
University Health Network has performed what is believed to be the first lung transplant in Canada on a patient whose lungs were irreparably damaged by COVID-19. Timothy Edwards Sauvé, 61, contracted the disease in December and was referred to UHN for a transplant assessment about two months later. After a careful assessment by a multidisciplinary team in the Toronto Lung Transplant Program at UHN's Ajmera Transplant Centre, Sauvé was listed and received the life-saving organ in February. "It's been quite a journey, and I'm very thankful to my medical team and my donor," says Sauvé who had no prior comorbidities that would put him at higher risk for infection or complications from the disease. "I was in great physical shape so I never thought I would get so sick from COVID. It still doesn't seem real to me, and I hope my story will show people how dangerous this disease can be."
34
May 2021
machine (ventilator) - which ultimately was also not enough to keep him alive. Once transferred to Toronto General Hospital, at UHN, he eventually needed the advanced lung support therapy called extracorporeal membrane oxygenation (ECMO) - which is essentially a machine that pumps and oxygenates the blood outside of the body providing healing time and relief to damaged lungs. "A few weeks after he cleared the virus, it was very clear from his scans that Sauvé's lungs were severely and permanently damaged, and would not recover. His only chance of survival would be by receiving a transplant," says Dr Marcelo Cypel, Surgical Director at the Ajmera Transplant Centre and the surgeon who led the team performing the transplant. Dr Cypel says transplant is certainly a life-saving treatment for a very small subgroup of COVID patients. However, with variants of concern increasingly infecting younger healthier patients during this third wave of the pandemic, the number of transplant referrals may grow. The programme is currently evaluating three additional COVID patients for transplantation candidacy.
Sauvé developed cold-like symptoms and screened positive for COVID-19 back in December. In a matter of days, the disease progressed, and he was hospitalized.
When to consider lung transplantation for COVID-19
As oxygen levels went down, he needed support from a mechanical breathing
There have been few cases of lung transplant after COVID reported around
Dr Marcelo Cypel, (L), seen here performing an unrelated surgery, says scans showed Timothy Edwards Sauvé’s lungs were so badly damaged by COVID-19 that “his only chance of survival would be by receiving a transplant.” the world, as it is only a recommended therapy in exceptional circumstances.
explored considerations for transplant assessment.
The majority of patients who develop severe COVID infection are usually not candidates for transplant, since other risk factors and complications from the disease would significantly compromise the chances of success for such a major surgery.
Sauvé was an ideal candidate for transplantation as he had no other comorbidities, and no other organs were significantly impacted by the COVID infection. Despite being on ECMO, he was awake and able to understand the implications and risks of transplantation.
"Transplant is not a cure for COVID," says Dr. Shaf Keshavjee, Director, Toronto Lung Transplant Program. "In this case, with ECMO support and intense rehabilitation, we were happy to see it provided a second chance of life for Sauvé. Given the nature of COVID infections, transplant is only recommended in exceptional conditions - where the lungs are truly destroyed from the disease without the hope of recovery, and the patient is strong enough to go through a lung transplant." Drs Cypel and Keshavjee have authored a scientific paper published in The Lancet Respiratory Medicine that
"We had one-on-one lengthy conversations so he understood the long road ahead of him, of the recovery journey after surgery, and the immunosuppression that comes with any transplant," says Dr Stephen Juvet, a transplant respirologist at UHN who was part of the team looking after Sauvé.
Recovery journey While no longer critically ill, patients that have spent prolonged time in hospital often require a period of inpatient rehabilitation to regain their strength before transitioning home.
Breathing with new lungs is one thing, but it can take time to work up the stamina and energy to use those lungs and re-train one's muscles to complete everyday tasks. After his transplant, Timothy Sauvé is recovering well. His lung function is excellent and he no longer requires any oxygen support. He has been transferred to UHN's Toronto Rehab Bickle Centre, where an active multidisciplinary team is helping him improve his mobility, lung function and quality of life. "Our primary goal is to improve a patient's independence and function. We learn about their home environment, interests, support system and hobbies to work with them to get back to the activities they enjoy," explains physiatrist Dr Alexandra Rendely. "We want to add life to the years that the transplant has afforded them."
Source: University Health Network
www.indiamedtoday.com
35
STUDY REPORT
Happy Nurses Critical to Better Outcome Nurses' physical, mental health connected to preventable medical errors
A study led by The Ohio State
well-being were twice as likely to have
University College of Nursing finds that
better physical health.’
critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health. The study, which was conducted before the COVID-19 pandemic, also found that ‘nurses who perceived that their worksite was very supportive of their
Study findings were published in the
American Journal of Critical Care. "It's
critically
important
that
we
understand some of the root causes that lead to those errors and do everything we can to prevent them," lead author Bernadette Melnyk said. She serves as vice president for health promotion, chief wellness officer and dean of the College of Nursing at Ohio State. The authors quoted research on the prevalence of stress, anxiety, depression and burnout symptoms among critical care nurses as a basis for examining the potential correlation between wellbeing and medical errors. The study surveyed nearly 800 members of the American Association of Critical-Care Nurses. "It's clear that critical care nurses, like so many other clinicians, cannot continue to pour from an empty cup," Melnyk said. "System problems that contribute to burnout and poor health need to be fixed. Nurses need support and
investment
programming
in
and
evidence-based resources
that
enhance their well-being and equip them with resiliency so they can take optimal care of patients." Study findings included: Bernadette Melnyk, chief wellness officer and Dean of the College of Nursing at The Ohio State University
36
May 2021
•
Of those surveyed, 61 per cent
reported suboptimal physical health,
The Buckeye Paws programme helps healthcare workers at The Ohio State University Wexner Medical Center cope with stressful situations. It’s one of several resources offered to staff to preserve their mental and physical health and prevent burnout. while 51 per cent reported suboptimal
health resources and services such
counselling and mindfulness, I was
mental health.
as counseling, mindfulness coaching
finally able to see that I didn’t need to
and its Stress, Trauma and Resilience
push my feelings down, and that there
(STAR) Program that offers the Buckeye
were healthy ways to feel and express
Paws pet therapy program to promote
the grief that comes with being a critical
building coping and resiliency skills.
care nurse.”
“I think the pandemic has brought
The authors mention that levels of
• Approximately
40
per
screened
for
depressive
positive
cent
symptoms and more than 50 per cent screened positive for anxiety. •
Those who reported worse health
and well-being had between a 31 per cent to 62 per cent higher likelihood of making medical errors. •
magnification to the issues of burnout, depression, even suicide amongst our nurses, physicians, and other clinicians,” Melnyk said. “A hospital’s investment
Nurses who reported working in
in
the
well-being
of
their
health
stress, anxiety and depression are likely even higher in the current environment than before the pandemic, when the study was conducted.
places that provided greater support for
care professionals will lead to better
"The major implication of this study's
wellness were more than twice as likely
quality and safety of care and fewer
findings for hospital leaders and policy
to have better personal health and
preventable medical errors.”
makers is that critical care nurses
professional quality of life compared with those whose workplace provided little or no support. The
Ohio
State
Center has several
“The feeling of being the person holding someone’s hand as they pass away is hard to describe, but it’s something I
Wexner
Medical to
impacted every aspect of my life,” said
promote clinician well-being, including
Jessica Curtisi, a critical care registered
its
Program
nurse in the Ohio State Wexner Medical
mental
Center intensive care unit. “Through
Employee
which
offers
programmes
definitely took home with me, and that
Assistance confidential
whose well-being is supported by their organizations are more likely to be fully engaged in patient care and make fewer medical errors, resulting in better patient outcomes and more lives saved," the researchers wrote.
Source: The Ohio State University College of Nursing
www.indiamedtoday.com
37
DETAIL NEWS
Battling Public Health Misinformation Online “Dear Pandemic has demonstrated that consistently content
publishing
outside
a
high-quality peer-reviewed
venue can result in incredible impact— personal behavior change, informed nodes of trust to further disseminate factual
information,
and
resources
for community providers navigating constantly evolving knowledge,” says Penn Nursing’s Ashley Z Ritter, PhD, CRNP, the article’s lead author. Dear
Pandemic
necessary
is
an
example
low-barrier
of
information
exchange with the public and a tool for community providers like nurses to stay informed of breaking news. Increased engagement of nurses in endeavors like
Dear
Pandemic
amplifies
the
impact of collective interdisciplinary Social media and web-based news
delivers
channels
and
became
a
communication
curated,
timely
comprehensive,
information
about
the
efforts to educate the public, contain misinformation, and motivate individual and systemic action, the article explains.
superhighway for correct and incorrect
COVID-19 pandemic in a question-and-
public health information during the
answer format. Complex topics such
“Now is the time for nurses to flex their
COVID-19 pandemic. The study of this
as COVID-19 aerosol transmission, risk
communication and trust muscles in
reduction strategies to avoid infection,
both traditional and innovative ways
and excess mortality are explained in
to advance the health of the public
common language and shared widely.
through trusted, actionable messaging
vast amount of information, known as infodemiology, is critical to building public health interventions to combat misinformation and help individuals,
in addition to exceptional patient care,”
groups, and communities navigate and
Now with more than 100,000 followers
distill crucial public health messages.
and accounts on Facebook, Twitter,
PhD, CRNP, a Fellow of the National
and Instagram, the campaign has an
Clinician Scholars Program.
In a novel effort to combat COVID-19 misinformation, a group of women
international and multilingual impact
researchers, including nurse scientists
offering important public health insight
from the University of Pennsylvania
via social media. An article in the journal
School
Nursing),
Public Health Nursing describes how the
launched the Dear Pandemic social
campaign is combating misinformation
media campaign in March 2020. It
about COVID-19.
38
of
May 2021
Nursing
(Penn
says co-author Shoshana Aronowitz,
The article “Dear Pandemic: Nurses as Key Partners in Fighting the COVID-19 Infodemic” is available online.
Source: University of Pennsylvania School of Nursing
The Evolving Cybersecurity Landscape Remote working has increased cyberthreats. But even after the global pandemic is over, it’s going to be important to take actionable steps to combat the sizable security risks.
Customized MVISION Device-to-Cloud Suites MVISION Advanced
|
MVISION Premium
|
MVISION Complete
We Recommend:
Implement a cloud-based secure web gateway
1 2 3 4 5 6
Require multi-factor authentication to reduce risks of credential theft
Set policy in the cloud for routine device checks
https://www.mcafee.com/enterprise/en-us/assets/reports/restricted/rp-carr-wfh.pdf https://www.mcafee.com/enterprise/en-us/assets/reports/restricted/rp-carr-wfh.pd Source: https://www.darkreading.com/cloud/as-cloud-adoption-grows-dlp-remains-key-challenge/d/d-id/1335000 https://newsroom.ibm.com/2020-07-29-IBM-Report-Compromised-Employee-Accounts-Led-to-Most-Expensive-Data-Breaches-Over-Past-Year https://www.gartner.com/smarterwithgartner/is-the-cloud-secure/ https://media.nominet.uk/wp-content/uploads/2019/02/12130924/Nominet-Cyber_CISO-report_FINAL-130219.pdf
8 https://www.mcafee.com/enterprise/en-us/assets/reports/rp-cloud-adoption-and-risk-report-work-from-home-edition.pdf McAfee and the McAfee logo are trademarks or registered trademarks of McAfee, LLC or its subsidiaries in the US and other countries. Other marks and brands may be claimed as the property of others. Copyright © 2020 McAfee, LLC. 4619_0920 SEPTEMBER 2020
www.indiamedtoday.com
39
40
May 2021
